| # | Drug | Count |
|---|---|---|
| 0 | DICLOFENAC SODIUM | 268 |
| 1 | RITUXIMAB | 266 |
| 2 | ACETAMINOPHEN | 263 |
| 3 | DICLOFENAC | 261 |
| 4 | ADALIMUMAB | 254 |
| 5 | METHOTREXATE SODIUM | 244 |
| 6 | NAPROXEN SODIUM | 243 |
| 7 | ADALIMUMAB-ADAZ | 237 |
| 8 | SULFASALAZINE | 231 |
| 9 | PANTOPRAZOLE | 228 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAFFEINE CITRATE | 135 | 0.0578 |
| 1 | HYDROCORTISONE BUTYRATE | 50 | 0.0253 |
| 2 | ASIAN GINSENG | 9 | 0.0213 |
| 3 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 13 | 0.0198 |
| 4 | NEOMYCIN OINTMENT | 47 | 0.0192 |
| 5 | TRICLOSAN | 11 | 0.0191 |
| 6 | DESOGESTREL AND ETHINYL ESTRADIOL | 51 | 0.0156 |
| 7 | PSEUDOEPHEDRINE HCL | 143 | 0.0131 |
| 8 | ACETAMINOPHEN AND CODEINE | 145 | 0.0118 |
| 9 | HYDROCORTISONE SODIUM SUCCINATE | 46 | 0.0115 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 314 |
| 1 | Corticosteroid [EPC] | 272 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 267 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 263 |
| 4 | Interleukin-17A Antagonist [EPC] | 252 |
| 5 | Aminosalicylate [EPC] | 247 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 245 |
| 7 | Vitamin C [EPC] | 233 |
| 8 | Antirheumatic Agent [EPC] | 223 |
| 9 | Angiotensin Converting Enzyme Inhibitor [EPC] | 220 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 37 | 0.0538 |
| 1 | Interleukin-17A Antagonist [EPC] | 252 | 0.0068 |
| 2 | Provitamin D2 Compound [EPC] | 201 | 0.0068 |
| 3 | Endoglycosidase [EPC] | 8 | 0.0043 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 29 | 0.0033 |
| 5 | Aminosalicylate [EPC] | 247 | 0.0025 |
| 6 | Human C1 Esterase Inhibitor [EPC] | 9 | 0.0023 |
| 7 | Antirheumatic Agent [EPC] | 223 | 0.0021 |
| 8 | Interleukin-23 Antagonist [EPC] | 219 | 0.0021 |
| 9 | Interleukin-12 Antagonist [EPC] | 216 | 0.0021 |